drugset / Trial / NCT06475430

Fecal Microbiota Transplantation in the Treatment of Major LARS

NCT06475430

Not yet recruiting 40 enrolled Peking University People's Hospital
RandomizedSequentialTriple-blindTreatment

Summary

Randomized trial to assess FMT efficacy in improving bowel function for major LARS patients. 40 subjects, blinded, randomized to FMT or probiotics. Pre-post 16S sequencing, 4-week follow-up for bowel symptoms, 8-week microbiota analysis.

Timeline

Start
2025-01-01
Primary completion
2026-06-30
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ornidazole Other / unclassified Other

Indications

No indication recorded.